Robert E. Bancroft

Insider Reports History

Location
Irvine, CA
Signature
/s/ Alexander Wilson, as Attorney-in-Fact, for Robert E. Bancroft
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert E. Bancroft:

Company Role Class Num Shares Value Price $ Report Date Ownership
AEON Biopharma, Inc. PRESIDENT & CEO, Director Class A Common Stock 3,177,103 $3,526,584 $1.11 17 Feb 2026 Direct
AEON Biopharma, Inc. PRESIDENT & CEO, Director Stock Option 59,034 29 Apr 2025 Direct

Insider Reports Filed by Robert E. Bancroft

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AEON AEON Biopharma, Inc. 17 Feb 2026 1 $0 4 PRESIDENT & CEO, Director 19 Feb 2026, 20:40
AEON AEON Biopharma, Inc. 14 May 2025 1 $0 4 President & CEO, Director 16 May 2025, 16:17
AEON AEON Biopharma, Inc. 29 Apr 2025 1 $0 4 President & CEO, Director 01 May 2025, 16:50
AEON AEON Biopharma, Inc. 29 Apr 2025 0 $0 3 President & CEO, Director 01 May 2025, 16:50